Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Schliephake, H, Sicilia, A, Nawas, BA, Donos, N, Gruber, R, Jepsen, S, Milinkovic, I, Mombelli, A, Navarro, JM, Quirynen, M, Rocchietta, I, Schiødt, M, Schou, S, Stähli, A & Stavropoulos, A 2018, 'Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018' Clinical Oral Implants Research, bind 29 Suppl 18, s. 93-99. https://doi.org/10.1111/clr.13270

APA

Schliephake, H., Sicilia, A., Nawas, B. A., Donos, N., Gruber, R., Jepsen, S., ... Stavropoulos, A. (2018). Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018. Clinical Oral Implants Research, 29 Suppl 18, 93-99. https://doi.org/10.1111/clr.13270

CBE

Schliephake H, Sicilia A, Nawas BA, Donos N, Gruber R, Jepsen S, Milinkovic I, Mombelli A, Navarro JM, Quirynen M, Rocchietta I, Schiødt M, Schou S, Stähli A, Stavropoulos A. 2018. Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018. Clinical Oral Implants Research. 29 Suppl 18:93-99. https://doi.org/10.1111/clr.13270

MLA

Vancouver

Author

Schliephake, Henning ; Sicilia, Alberto ; Nawas, Bilal Al ; Donos, Nikos ; Gruber, Reinhard ; Jepsen, Søren ; Milinkovic, Iva ; Mombelli, Andrea ; Navarro, Jose Manuel ; Quirynen, Marc ; Rocchietta, Isabella ; Schiødt, Morten ; Schou, Søren ; Stähli, Alexandra ; Stavropoulos, Andreas. / Drugs and diseases : Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018. I: Clinical Oral Implants Research. 2018 ; Bind 29 Suppl 18. s. 93-99.

Bibtex

@article{684d9b2e05d24d5087162c8d63d3a2b1,
title = "Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018",
abstract = "OBJECTIVES: The task of this working group was to update the knowledge about the use of drugs and biologicals affecting healing of soft tissue and bone during implant treatment or procedures associated with it. Moreover, the impact of titanium particles and biocorrosion on complications and implant survival has been analysed.MATERIALS AND METHODS: The literature in the areas of interest (platelet concentrates, antiresorptive drugs as well as implant-host interaction) was screened using systematic reviews for the former two areas, whereas a narrative critical review was performed for the latter topic. Two manuscripts on platelet concentrates, one manuscript on antiresorptive drugs and one manuscript on the effects of biocorrosion, were presented for group analysis with subsequent discussion in the plenum and final consensus approval.RESULTS: Results and conclusions of the individual reviews of the three topics are presented in the respective papers. Conclusions of the group on strengths and weaknesses of available evidence as well as consensus statements and directions for further research are provided in this study. The following papers were subject to group discussions and formed the basis for the consensus statements: St{\"a}hli A, Strauss FJ, Gruber R. () The use of platelet-rich-plasma to enhance the outcomes of implant-related therapies: a systematic review Strauss FJ, St{\"a}hli A, Gruber R. (2018) The use of platelet-rich-fibrin to enhance the outcomes of implant-related therapies: a systematic review Mombelli A, Hashim D, Cionca N. () What is the impact of titanium particles and bio-corrosion on implant survival and complications? A critical review Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Morten Schi{\o}dt, Klinge B. () The effect of antiresorptive drugs on implant therapy: a systematic review.",
author = "Henning Schliephake and Alberto Sicilia and Nawas, {Bilal Al} and Nikos Donos and Reinhard Gruber and S{\o}ren Jepsen and Iva Milinkovic and Andrea Mombelli and Navarro, {Jose Manuel} and Marc Quirynen and Isabella Rocchietta and Morten Schi{\o}dt and S{\o}ren Schou and Alexandra St{\"a}hli and Andreas Stavropoulos",
note = "{\circledC} 2018 The Authors. Clinical Oral Implants Research Published by John Wiley & Sons Ltd.",
year = "2018",
month = "10",
doi = "10.1111/clr.13270",
language = "English",
volume = "29 Suppl 18",
pages = "93--99",
journal = "Clinical Oral Implants Research",
issn = "0905-7161",
publisher = "Wiley-Blackwell Munksgaard",

}

RIS

TY - JOUR

T1 - Drugs and diseases

T2 - Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018

AU - Schliephake, Henning

AU - Sicilia, Alberto

AU - Nawas, Bilal Al

AU - Donos, Nikos

AU - Gruber, Reinhard

AU - Jepsen, Søren

AU - Milinkovic, Iva

AU - Mombelli, Andrea

AU - Navarro, Jose Manuel

AU - Quirynen, Marc

AU - Rocchietta, Isabella

AU - Schiødt, Morten

AU - Schou, Søren

AU - Stähli, Alexandra

AU - Stavropoulos, Andreas

N1 - © 2018 The Authors. Clinical Oral Implants Research Published by John Wiley & Sons Ltd.

PY - 2018/10

Y1 - 2018/10

N2 - OBJECTIVES: The task of this working group was to update the knowledge about the use of drugs and biologicals affecting healing of soft tissue and bone during implant treatment or procedures associated with it. Moreover, the impact of titanium particles and biocorrosion on complications and implant survival has been analysed.MATERIALS AND METHODS: The literature in the areas of interest (platelet concentrates, antiresorptive drugs as well as implant-host interaction) was screened using systematic reviews for the former two areas, whereas a narrative critical review was performed for the latter topic. Two manuscripts on platelet concentrates, one manuscript on antiresorptive drugs and one manuscript on the effects of biocorrosion, were presented for group analysis with subsequent discussion in the plenum and final consensus approval.RESULTS: Results and conclusions of the individual reviews of the three topics are presented in the respective papers. Conclusions of the group on strengths and weaknesses of available evidence as well as consensus statements and directions for further research are provided in this study. The following papers were subject to group discussions and formed the basis for the consensus statements: Stähli A, Strauss FJ, Gruber R. () The use of platelet-rich-plasma to enhance the outcomes of implant-related therapies: a systematic review Strauss FJ, Stähli A, Gruber R. (2018) The use of platelet-rich-fibrin to enhance the outcomes of implant-related therapies: a systematic review Mombelli A, Hashim D, Cionca N. () What is the impact of titanium particles and bio-corrosion on implant survival and complications? A critical review Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Morten Schiødt, Klinge B. () The effect of antiresorptive drugs on implant therapy: a systematic review.

AB - OBJECTIVES: The task of this working group was to update the knowledge about the use of drugs and biologicals affecting healing of soft tissue and bone during implant treatment or procedures associated with it. Moreover, the impact of titanium particles and biocorrosion on complications and implant survival has been analysed.MATERIALS AND METHODS: The literature in the areas of interest (platelet concentrates, antiresorptive drugs as well as implant-host interaction) was screened using systematic reviews for the former two areas, whereas a narrative critical review was performed for the latter topic. Two manuscripts on platelet concentrates, one manuscript on antiresorptive drugs and one manuscript on the effects of biocorrosion, were presented for group analysis with subsequent discussion in the plenum and final consensus approval.RESULTS: Results and conclusions of the individual reviews of the three topics are presented in the respective papers. Conclusions of the group on strengths and weaknesses of available evidence as well as consensus statements and directions for further research are provided in this study. The following papers were subject to group discussions and formed the basis for the consensus statements: Stähli A, Strauss FJ, Gruber R. () The use of platelet-rich-plasma to enhance the outcomes of implant-related therapies: a systematic review Strauss FJ, Stähli A, Gruber R. (2018) The use of platelet-rich-fibrin to enhance the outcomes of implant-related therapies: a systematic review Mombelli A, Hashim D, Cionca N. () What is the impact of titanium particles and bio-corrosion on implant survival and complications? A critical review Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Morten Schiødt, Klinge B. () The effect of antiresorptive drugs on implant therapy: a systematic review.

U2 - 10.1111/clr.13270

DO - 10.1111/clr.13270

M3 - Journal article

VL - 29 Suppl 18

SP - 93

EP - 99

JO - Clinical Oral Implants Research

JF - Clinical Oral Implants Research

SN - 0905-7161

ER -

ID: 56437163